Bank of America
GERM

Bank of America’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History

Bank of America’s Portfolio GERM Stock Details GERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$6K – 7893
2020
Q4 		$6K Buy
+200
New +$6.09K ﹤0.01% 6806

Other funds holding GERM

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
G
Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Bank of America's GERM Position: Q1 2021 in Review

Bank of America sold out of Amplify Treatments, Testing and Advancements ETF (GERM) in Q1 2021, closing a stake of 200 shares — an estimated $6K sold.

Bank of America first reported a position in GERM in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 22 funds tracked by Wall St. Rank hold GERM as of Q1 2021.

  • Bank of America reported no remaining Amplify Treatments, Testing and Advancements ETF position as of Q1 2021 after selling out during the quarter.
  • Bank of America sold 200 Amplify Treatments, Testing and Advancements ETF shares in Q1 2021, an estimated $6K.
  • Bank of America first reported a position in Amplify Treatments, Testing and Advancements ETF in Q4 2020 and held it in 1 quarter.
  • Bank of America's Amplify Treatments, Testing and Advancements ETF position peaked at $6K in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Amplify Treatments, Testing and Advancements ETF as of Q1 2021.

Based on Bank of America's 13F filing for Q1 2021, filed 14 May 2021.